Concepedia

Publication | Closed Access

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort

DOI

215

Citations

20

References

2011

Year

M. Cossburn, Adrian Pace, Joanne Jones, R. Ali, Gillian Ingram, K. Baker, Claire Hirst, John Zajicek, Neil Scolding, M. Boggild,
Neurology

Abstract

This study provides Class IV evidence that the risk of AID after alemtuzumab treatment for MS is time-limited and modified by external factors.

References

YearCitations

Page 1